Combining Multi-omics Analysis and Organoid Models to Search for Novel Therapy Target in Metastatic Prostate Cancer
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The aim of this study is to use multiomics sequencing to explore the molecular characteristics of metastatic prostate cancer (mPCa), especially metastatic castration-resistant prostate cancer (mCRPC). At the same time, mCRPC models will be constructed, including organoids and animal models, serving as a basic and translational research platform to help identify novel drug targets for mPCa.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Histologically confirmed prostate cancer
• metastatic disease confirmed by image examination
• Patients who can undergo surgery or biopsy for prostate cancer
• Able to provide informed consent
Locations
Other Locations
China
Fudan University Shanghai Cancer Center
RECRUITING
Shanghai
Contact Information
Primary
Yao Zhu
mailzhuyao@163.com
+86 15001818005
Time Frame
Start Date: 2023-08-01
Estimated Completion Date: 2028-12-01
Participants
Target number of participants: 100
Treatments
All patients
There is only one arm in the trial
Related Therapeutic Areas
Sponsors
Leads: Fudan University